Skip to main content

Table 1 Baseline participant characteristics

From: Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status

 

IBD (n = 24)

Non-IBD Controls (n = 20)

Pvalue

Age (mean +/− range)

45 (19–90)

56 (22–88)

0.045

Female:Male

7:17

11:9

0.153

Co-morbid illnesses, n (%)

Type 2 diabetes mellitus

2

3

 

Chronic kidney disease

1

0

 

Atrial fibrillation

1

0

 

Ischaemic heart disease

1

2

 

Colorectal adenocarcinoma

0

1

 

Other cancer

1

3

 

Body mass index (mean +/− range)

26.9 (17.6–51.3)

26.5 (5.43)

0.866

Haemoglobin (g/L, mean, range)

121 (62–153)

124 (86–162)

0.597

MCV (10−15L, mean, range)

82 (55–96)

81 (68–88)

0.601

Serum ferritin (ng/mL, mean, range)

30 (3–93)

25 (7–62)

0.395

White cell count (×  109/L, mean, range)

7.6 (4.0–10.9)

6.8 (3.7–21.4)

0.416

Platelet count (× 109/L, mean, range)

318 (150–680)

237 (143–366)

0.009

eGFR (mL/min/1.73m2, mean, range)

85 (38 - > 90)

80 (45- > 90)

0.273

Serum albumin (g/L, mean, range)

35 (25–48)

38 (30–50)

0.064

Serum C-reactive protein (mg/L, median, range)

3 (< 2–18)

< 2 (< 2–15)

0.228

Faecal calprotectin (μg/g, median, range)

573 (< 15- > 3000)

47 (< 15–300)

0.023

25(OH) vitamin D (nmol/L, mean, range)

51 (8–104)

49 (20–96)

0.822

1,25(di-OH) vitamin D (pmol/L, mean, range)

112 (50–202)

136 (62–263)

0.109

Serum calcium (corrected, mmol/L, mean ± 95% CI)

2.40 (2.29–2.49)

2.36 (2.21–2.55)

0.115

Serum phosphate (mmol/L, mean ± 95% CI)

1.11 (0.69–1.39)

1.09 (0.63–1.60)

0.700

Serum parathyroid hormone (pmol/L, mean ± 95% CI)

5.1 (1.9–12.1)

6.3 (1.4–11.5)

0.103

  1. Unpaired t-test unless otherwise specified
  2. Chi-square